Target intelligence / Profile preview

Coccidian intracellular stages

Molecular classification
Other
01

Overview

Coccidian intracellular stages refer to the complex developmental phases of apicomplexan protozoan parasites, such as Eimeria, Toxoplasma, and Cryptosporidium, that occur within the cells of a host organism. These stages include merogony (asexual replication) and gametogony (sexual development), which are responsible for the massive multiplication of the parasite and subsequent tissue damage, particularly in the intestinal epithelium (MSD Veterinary Manual). Because these stages are intracellular, they are protected from many components of the host immune system, making them a primary focus for pharmacological intervention. Drugs like toltrazuril and ponazuril are specifically designed to penetrate host cells and interfere with the parasite's organelle function, such as the apicoplast or mitochondria, effectively halting the life cycle (PubMed, PMID: 12622931). While 'Coccidian intracellular stages' is a biological category rather than a single molecular target, it is frequently used in phenotypic drug discovery and veterinary medicine to describe the broad efficacy of anticoccidial agents. Understanding these stages is critical for managing coccidiosis, a major economic burden in the poultry and livestock industries, as well as opportunistic infections in immunocompromised humans.

Other names
CoccidiaIntracellular stages of EimeriaApicomplexan intracellular stagesSchizontsMerozoitesGametocytes
02

Mechanism of action

Drugs targeting these stages typically act by inhibiting nuclear division, disrupting the function of the apicoplast (a non-photosynthetic plastid), interfering with mitochondrial respiration, or competitively inhibiting essential nutrient transport such as thiamine uptake.

03

Biological functions

Parasite replicationHost cell invasionAsexual reproduction (Schizogony)Sexual reproduction (Gamatogony)Metabolism
04

Disease associations

InfectionCoccidiosisToxoplasmosisCryptosporidiosisSarcocystosis
05

Safety considerations

Rapid development of drug resistanceNarrow therapeutic index (especially for ionophores like Monensin)Potential embryotoxicity in certain speciesEnvironmental persistence of drug residues
06

Interacting drugs

Toltrazuril

7 more in the full profile.

07

Biomarkers

Oocysts per gram (OPG) in fecesIntestinal lesion scoresParasite-specific DNA (via PCR)Serum antibody titers

Beyond the preview

Go deeper on Coccidian intracellular stages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coccidian intracellular stages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call